none
Conditions
Interventions
1. Educational Seminars - Content: COVID-19 Clinical Practice Guidelines, Proper Use of Oral Antiviral Drugs, and Case Review-Format: 60-Minute Face-to-Face Study Group or Web Video Streaming - Instr
Sponsors
Kazuko Yamamoto
Eligibility
Inclusion criteria
Inclusion criteria: 1.Medical professionals such as physicians, nurses, and pharmacists working in clinics and hospitals within the study area 2.Medical professionals who may be involved in COVID-19 medical care and oral antiviral drug prescription 3.Those who have given their consent to participate in the study 4.Those who are able to participate in educational seminars or watch web-based videos during the study period 5.Those who are able to contact them by e-mail and answer electronic questionnaires.
Exclusion criteria
Exclusion criteria: 1.Those who are expected to have difficulty in continuous participation due to transfer, retirement, etc. during the study period 2.Those who have difficulty in participating in the educational seminar (if neither face-to-face nor web-delivered participation is available) 3.Those who are unable to cooperate in completing the questionnaire 4.Those who belong to a department or job type completely unrelated to COVID-19 medical care.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Prescription Behaviors of Healthcare Professionals (Assessed by Questionnaire Surveys Before and After Intervention) Specifically, changes in scores of questionnaire surveys including the following indicators: - Perceptions of Indications for COVID-19 Oral Antiviral Drugs - Process of Appropriate Prescription Decisions - Drug Interaction Confirmation Behaviors - Implementation of Adverse Drug Reaction Monitoring. | — |
Contacts
Public ContactKami Wakaki
University of the Ryukyus Graduate School of Medicine
Outcome results
None listed